HIF-1α and EPO receptor proteins are elevated in the hippocampus of patients with Alzheimer’s disease along with a decrease in GLUT1, GLUT3, and EPO protein [83,93]. Here, SLC2A3 is linked to early-onset autosomal dominant Alzheimer disease.